Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
0.6825
-0.0264 (-3.72%)
At close: Sep 12, 2025, 4:00 PM EDT
0.6890
+0.0065 (0.95%)
After-hours: Sep 12, 2025, 7:57 PM EDT
Iterum Therapeutics Market Cap
Iterum Therapeutics has a market cap or net worth of $30.48 million as of September 12, 2025. Its market cap has increased by 14.73% in one year.
Market Cap
30.48M
Enterprise Value
50.01M
1-Year Change
14.73%
Ranking
Category
Stock Price
$0.68
Market Cap Chart
Since May 25, 2018, Iterum Therapeutics's market cap has decreased from $179.38M to $30.48M, a decrease of -83.01%. That is a compound annual growth rate of -21.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 30.48M | -37.42% |
| Dec 31, 2024 | 48.70M | 84.01% |
| Dec 29, 2023 | 26.47M | 157.57% |
| Dec 30, 2022 | 10.28M | -85.65% |
| Dec 31, 2021 | 71.61M | 47.53% |
| Dec 31, 2020 | 48.54M | -27.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 25, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.94B |
| Johnson & Johnson | 429.89B |
| AbbVie | 389.03B |
| UnitedHealth Group | 320.26B |
| AstraZeneca | 251.66B |
| Novartis AG | 247.58B |
| Novo Nordisk | 241.70B |
| Abbott Laboratories | 230.87B |